References
- Ruffatti A, ArsIan P, Eloreani A, de Silvestro G, Calligaro A, Naccarato R, et al. Nuclear membrane staining anti-nuclear anti-body in patients with primary biliary cirrhosis. J Clin Immunol 1985;5:357–61.
- Lozano FL, Pares A, Borche L, Plana M, Gallart T, Rodes J, et al. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 1988;8:930-8.10.
- Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210 kilodalton nuclear envelope polypeptide recognized by 11. human autoantibodies in primary biliary cirrhosis is the glycopro-tein of the nuclear pore. J Clin Invest 1990;86: 279–85.
- Nickowitz RW, Wozniak PW, Schffner F, Worman HJ. Autoanti-bodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994; 106:193-9.12.
- Shibata M, Ueno Y, Onozuka Y, Kawaguchi N, Oda Y, Hiwatashi T, et al. Autoantibodies against nuclear envelope in patients with primary biliary cirrhosis. Int Hepatol Commun 1995;4:46-53.13.
- Gadek JW, Hohenauer H, Hitchman E, Penner E. Autoantibodies against nudeoporin p62 constitute a novel marker of primary bil- iary cirrhosis. Gastroenterology 1996;110:840-7.14.
- Kita K, Omata S, Horigome T. Purification and characterization of a nuclear pore glycoprotein complex containing p62. J Biochem 1993;113: 377–82.
- Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 15. patients with primary biliary cirrhosis. N Engl J Med 1973;289:674–8.
- Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on analysis of 236 patients. Gastroenterology 1980;78:236–46.
- Floreani A, Chiaramonte M, Fabris P, Naccarato R. Primary bil-iary cirrhosis in the elderly. Recenti Prog Med 1991;82:2–5.
- Shibata M, Ouya K, Hachiya T, Tamai K, Miyachi K, Horigome T, et al. Detection of anti-gp210 antibodies in primary biliary cirrhosis by enzyme-linked immunosorbent assay with a synthesized polypeptide. In: Yamanaka M, Toda G, Tanaka T, editors. Pro-gress in hepatology, Vol. 5. Liver and immunology. Amsterdam: Elsevier; 1999. p. 125–33.
- Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. PBC sera recognize not only gp210 but also p62 complex pro-teins bearing N-acetylglucoseamine residues from rat liver nuclear envelope. Mol Biol Rep 1996;23:227–34.
- Miyachi K, Watanabe S, Yamashiki M, Hiwatashi T, Ichida F. Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis. Am J Gastroenterol 1984;79:704–9.
- Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, et al. Autoantibodies against a 210-kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with pri-mary biliary cirrhosis. J Gastroenterol Hepatol 1998;13: 257–65.
- Tsuneyama K, Water JVD, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the lumina' surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995;21:1031–7.